Novavax Consensus Price Target Raised 13.54% to $14.39
The average one-year price target for Novavax (NASDAQGS:NVAX) (LSE:0A3S) has been revised to $14.39 / share. This is an increase of 13.54% from the prior estimate of $12.68 dated October 30, 2026. These figures represent aggregate analyst targets collected from multiple sources a